pramlintide glp 1 What is the pipeline for future medications for obesity? Focus on Glucagon-like Peptide-1 Target:

Thyroid hormone regulation of metabolism

GLP-1 agonists were originally approved to treat Type 2 Diabetes (T2D) but their most recent incarnations, which consist of both next generation GLP-1s and combinations (Ozempic, Mounjaro, Wegovy, Zepbound), have moved beyond the realm of T2D into the treatment of obesity

Key Research Applications Hair Follicle Studies: Used in models examining follicle cycling and dermal papilla cell behavior

And trips to Penn State are fun again

These powerful medications, first developed to treat type 2 diabetes, are now widely used for weight loss, blood sugar control, and improving overall metabolic health

This genetic reset is key to its anti-aging and restorative abilities, helping your body build healthier tissue from the ground up